Company Filing History:
Years Active: 1991-1993
Title: Joseph E Griffith: Innovator in Antimicrobial Polypeptides
Introduction
Joseph E Griffith is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of antimicrobial agents through his innovative research and inventions. With a total of 2 patents, Griffith has focused on developing novel polypeptides that serve as effective antimicrobial agents.
Latest Patents
Griffith's latest patents include groundbreaking work on DNA encoding novel antimicrobial polypeptides and methods for obtaining them. This invention provides a purified polypeptide that is useful as an antimicrobial agent. The polypeptide has been derived from human granulocytes, with a molecular weight of approximately 3,700 daltons. The N-terminal amino acid sequence of this polypeptide is val-cys-ser-cys-arg-leu-val-phe-cys-arg-arg-thr-glu-leu-arg-val-gly-asn-cys-leu-ile-gly-gly-val-ser-phe-thr-tyr-cys-cys-thr-arg-val. Additionally, this invention outlines methods for producing the polypeptide, pharmaceutical compositions containing it, and various uses thereof.
Career Highlights
Throughout his career, Joseph E Griffith has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Invitron Limited and Incyte Pharmaceuticals, Inc. His work has significantly impacted the development of antimicrobial therapies.
Collaborations
Griffith has collaborated with esteemed colleagues, including Craig G Wilde and Marian N Marra. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Joseph E Griffith stands out as an influential inventor in the field of antimicrobial polypeptides. His innovative patents and collaborations have paved the way for advancements in antimicrobial therapies, showcasing his dedication to improving public health.